Status:
COMPLETED
Penehyclidine for PONV Prophylaxis After Strabismus Surgery
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
PONV
Eligibility:
All Genders
3-65 years
Phase:
PHASE4
Brief Summary
Patients scheduled for elective strabismus surgery under general anesthesia in the First Affiliated Hospital of Nanjing Medical University will be included in this study. Patients 1)ASA I or II, 2)ag...
Eligibility Criteria
Inclusion
- ASA I or II
- Aged 3-65 years
- Scheduled for elective strabismus surgery under general anesthesia
Exclusion
- Had prior PONV
- Severe motion sickness
- A history of ophthalmic surgery
- Had received drugs known to have antiemetic effects in 24h before surgery
Key Trial Info
Start Date :
July 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT04054479
Start Date
July 20 2019
End Date
November 1 2019
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210029